All News

Telehealth visits were just as effective as in-person visits at managing patients initiating apremilast.

Automated ventilatory burden can effectively assess obstructive sleep apnea (OSA) severity, estimate cardiovascular (CVD) mortality, and may present a promising alternative to apnea-hypopnea index (AHI).

A recent CDC study revealed that reports of mistreatment and discrimination during maternity care were high among Black, Hispanic, and multiracial respondents.

Patients with polycythemia vera (PV) and essential thrombocythemia (ET) require repeated molecular testing and improved prognostic tools.

The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma.

Older age was the main risk factor for advanced neoplasia, but family history of colorectal cancer had little association with advanced neoplasia incidence in a recent study.

Study results suggest the greatest risk for Clostridioides difficile infection was observed with use of clindamycin while the lowest risk was observed with doxycycline and minocycline.

Patients with advanced or metastatic non–small cell lung cancer (NSCLC) were able to specify a 1-point threshold when describing meaningful symptom change, for better or worse, that helped illustrate their symptom experience.

Over the past 20 years, the age-adjusted mortality rate for obesity-related cardiovascular mortality increased by 415% for American Indian or Alaska Native individuals.

Perampanel was found effective and safe for prolonged use in children with epilepsy, according to one study.

Michael Petrosky, MD, of Allegheny Health Network, spoke about the difference between vaccines and monoclonal antibodies and how they can affect treatment in respiratory syncytial virus (RSV).

FDA approves updated COVID-19 booster vaccines; low donor turnout and climate disasters result in a national blood shortage; minority patients discouraged by lack of doctor diversity.

Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, discusses treatment options available to patients with rare diseases, as well as the challenges these patients and their pharmacists face in accessing these treatments.

An intervention for Black women living with HIV was shown to have improved perceived outcomes when incorporating a support network and when the program structure emphasized trust.

As patients’ atopic dermatitis (AD) worsens, the risk of inflammatory bowel disease, Crohn disease, and ulcerative colitis increases.

Insomnia, along with other sleep disorders, were found to negatively impact workplace productivity.

There are multiple treatment options becoming available for diffuse large B-cell lymphoma, but more work needs to be done to understand their efficacy and in what lines of therapy they should be used.

Boys who smoke in their early teens increase risk of their future children developing asthma, obesity, and low lung function, a study suggests.

New research suggests an association between gestational diabetes history and mortality over 30 years, regardless of whether it manifests into type 2 diabetes.

Carmen Solórzano, MD, FACS, of Vanderbilt University Medical Center (VUMC), discusss how VUMC uses technology to advance cancer treatments and her current research.

Higher-cost therapies for age-related macular edema (ARMD) were significantly more likely to be prescribed by ophthalmologists accepting manufacturer payments.

Navigating mask mandates and vaccine recommendations; Biden administration wants employers to have naloxone on hand; NIH nominee to receive a confirmation hearing.

Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.

The phase 3 ENGOT-ov50/GOG-3029/INNOVATE-3 trial found the addition of tumor treating fields (TTFields) to paclitaxel did not provide a statistically significant improvement in overall survival (OS) vs paclitaxel alone for patients with platinum-resistant ovarian cancer, failing to meet its primary end point.

The researchers demonstrated how to jointly examine prevalence estimates of chronic obstructive pulmonary disease (COPD) from PLACES and social vulnerability measures from the Social Vulnerability Index developed by the CDC and the Agency for Toxic Substances and Disease Registry.

Ponatinib also produces an improvement in progression-free survival compared with imatinib among those with Philadelphia chromosome-positive acute lymphoblastic leukemia in the phase 3 PhALLCON trial.

Cordavis is a new subsidiary from CVS Health Corporation that will work with manufacturers to commercialize and coproduce biosimilars, beginning with an adalimumab product.

The highest proportions of patients with severe ocular impairment at baseline showed greater improvements in symptom severity on ravulizumab in comparison with placebo after 26 weeks.

A study found that negative experiences and concern for future children's health drive hemophilia carriers to choose prenatal tests, with cognitive factors playing a role.

New research suggests conventional fractionated and hypofractionated proton postmastectomy radiotherapy (PMRT) yield similar tolerability and complication rates for patients following mastectomy.